Skip to main content

Table 1 Baseline characteristics in patients with poor and good collaterals

From: Influence of high-density lipoprotein cholesterol on coronary collateral formation in a population with significant coronary artery disease

Variables Poor collateral Good collateral P value
  (n = 311) (n = 190)  
Age (years) 62.8 ± 12.9 62.1 ± 12.1 0.547
Gender (Female, %) 22.5 18.4 0.309
DM (%) 42.8 40.5 0.642
HTN (%) 64.3 65.3 0.848
Smoking (%) 60.5 58.2 0.639
BMI 24.3 ± 6.6 24.9 ± 5.7 0.277
eGFR (mL/min/1.73 m2) 66.9 ± 26.9 68.0 ± 32.0 0.683
Laboratory data    
Glucose (mg/dl) 137.7 ± 62.2 135.4 ± 60.4 0.704
Cholesterol (mg/dl) 199.7 ± 45.1 208.3 ± 53.6 0.060
LDL-C (mg/dl) 128.7 ± 38.3 136.2 ± 43.5 0.066
HDL-C (mg/dl) 37.4 ± 9.9 36.0 ± 10.6 0.175
Triglyceride (mg/dl) 168.9 ± 124.9 163.4 ± 146.4 0.660
Uric acid (mg/dl) 6.54 ± 1.94 6.58 ± 1.81 0.819
Medication    
ACEI (%) 19.1 20.7 0.725
ARB (%) 15.9 22.3 0.09
Beta blocker (%) 28 36.7 0.054
  1. ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin II receptor blocker; BMI: body mass index; DM: diabetes; HTN: hypertension; eGFR: estimated glomerular filtration rate; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol.